High Octane: Lonza buys 80% of ‘game-changing’ cell therapy tech partnerAllbiopro2018-10-31T10:09:59+09:0010월 31st, 2018|
Milestone Pharmaceuticals Announces $80 Million Private FinancingAllbiopro2018-10-31T10:09:30+09:0010월 31st, 2018|
Stora Enso acquires Swedish cellulose technology companyAllbiopro2018-10-31T10:09:02+09:0010월 31st, 2018|
Bioactive novel compounds from endangered tropical plant speciesAllbiopro2018-10-31T10:08:35+09:0010월 31st, 2018|
3D ‘organ on a chip’ could accelerate search for new disease treatmentsAllbiopro2018-10-31T10:08:08+09:0010월 31st, 2018|
Sterile, Integrated Hood and Mask for Larger Heads and HairstylesAllbiopro2018-10-31T10:06:44+09:0010월 31st, 2018|
Lonza Acquires a Controlling Stake in Octane Biotech for Cell Therapy TechnologyAllbiopro2018-10-31T10:06:17+09:0010월 31st, 2018|
Biogen and Samsung Bioepis Launch of Humira Biosimilar in EuropeAllbiopro2018-10-31T10:05:24+09:0010월 31st, 2018|
To Support Global Rollout of Novel Vaccines, Johnson & Johnson Unveils New Vaccines Launch FacilityAllbiopro2018-10-30T09:02:41+09:0010월 30th, 2018|
Esperion Eyes Early 2019 to File NDA for Cholesterol-Lowering TherapyAllbiopro2018-10-30T09:02:13+09:0010월 30th, 2018|
Updated: BioSpace’s List of October 2018 Life Sciences IPOsAllbiopro2018-10-30T09:01:47+09:0010월 30th, 2018|
We Want to Hear from You! 2018 Life Sciences InfluencersAllbiopro2018-10-30T09:01:22+09:0010월 30th, 2018|
Natural Protein Caused Fat Mice to Lose 33% of WeightAllbiopro2018-10-30T09:00:55+09:0010월 30th, 2018|
Roche’s Faricimab Shows Long-Term Durability in Macular DegenerationAllbiopro2018-10-30T09:00:30+09:0010월 30th, 2018|
Takeda’s $80 Billion Acquisition of Shire Hits Snag in EuropeAllbiopro2018-10-30T09:00:04+09:0010월 30th, 2018|
FDA Action Alert: Merck’s Keytruda in Lung Cancer, Trevena and AcelRx Drugs for PainAllbiopro2018-10-30T08:59:36+09:0010월 30th, 2018|
